Surgical Trauma-induced CCL2 Upregulation Mediates Lung Cancer Progression by Promoting Treg Recruitment in Mice and Patients

Cancer Invest. 2022 Feb;40(2):91-102. doi: 10.1080/07357907.2021.1977314. Epub 2021 Sep 27.

Abstract

Surgical removal of the tumor is currently the first-line treatment for lung cancer, but the procedure may accelerate cancer progression through immunosuppression. However, whether CCL2 (C-C motif chemokine ligand 2) enhances cancer progression by affecting regulatory T cells (Tregs) remains unknown. We found that the volume and weight of tumors were larger in the surgical trauma group than in the control group. CCL2 expression and Treg abundance were increased in tumor tissues after surgical trauma, and CCL2 expression was positively associated with Treg abundance. These results demonstrated that surgical trauma contributes to lung cancer progression by increasing CCL2 expression, thus promoting Treg recruitment.

Keywords: CCL2; Treg; immunosuppression; lung cancer; prognosis.

MeSH terms

  • A549 Cells
  • Aged
  • Animals
  • Carcinoma, Non-Small-Cell Lung / metabolism
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Case-Control Studies
  • Chemokine CCL2 / metabolism*
  • Disease Progression
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms / metabolism
  • Lung Neoplasms / pathology*
  • Male
  • Mice
  • Middle Aged
  • Neoplasm Transplantation
  • T-Lymphocytes, Regulatory / metabolism
  • Thoracotomy / adverse effects*
  • Up-Regulation*

Substances

  • CCL2 protein, human
  • Chemokine CCL2